These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

70 related items for PubMed ID: 6464876

  • 1. [Relationship between the types of diabetic retinopathy and the changes of hemostatic pathology].
    Kuwae Y.
    Nippon Ganka Gakkai Zasshi; 1984 Mar; 88(3):572-9. PubMed ID: 6464876
    [No Abstract] [Full Text] [Related]

  • 2. [Antithrombin III and alpha-2-antiplasmin activities compared with other hemostasis parameters in uncomplicated diabetes mellitus, type 2].
    Kotschy M, Drewniak W, Graczykowska-Koczorowska A, Listopadzki D.
    Pol Tyg Lek; 1984 Mar; 47(1-2):17-8. PubMed ID: 1409034
    [Abstract] [Full Text] [Related]

  • 3. [Alpha 2-antiplasmin in diabetes mellitus and its relation to diabetic retinopathy].
    Sánchez Martín S, García Díez LC, García Marcos MA, Miralles García JM.
    Rev Clin Esp; 1983 May 15; 169(3):189-90. PubMed ID: 6612032
    [No Abstract] [Full Text] [Related]

  • 4. [Hemostasis in burn patients and treatment with heparin. Relation to prognosis and infection. Pattern of blood levels of prekallikrein, alpha-2-macroglobulin, antithrombin III, plasminogen and alpha-2-antiplasmin].
    Hainaut J, Dhennin C, Guilbaud J.
    Nouv Rev Fr Hematol (1978); 1982 May 15; 24(6):375-81. PubMed ID: 6188103
    [Abstract] [Full Text] [Related]

  • 5. Fifteen coagulation and fibrinolysis parameters in diabetes mellitus and in patients with vasculopathy.
    Christe M, Fritschi J, Lämmle B, Tran TH, Marbet GA, Berger W, Duckert F.
    Thromb Haemost; 1984 Oct 31; 52(2):138-43. PubMed ID: 6084321
    [Abstract] [Full Text] [Related]

  • 6. [Changes in general hemostasis in patients with diabetic retinopathy].
    Evgrafov VIu, Markova OA, Grishin VL, Efimov VS.
    Vestn Oftalmol; 2004 Oct 31; 120(3):29-31. PubMed ID: 15216770
    [Abstract] [Full Text] [Related]

  • 7. [Dynamic changes in the hemostatic indices of diabetics during biostator control].
    Petkova M, Kamenov V, Tsanev A.
    Vutr Boles; 1989 Oct 31; 28(5):41-5. PubMed ID: 2482584
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Diabetes, a hypercoagulable state? Hemostatic variables in newly diagnosed type 2 diabetic patients.
    Hughes A, McVerry BA, Wilkinson L, Goldstone AH, Lewis D, Bloom A.
    Acta Haematol; 1983 Oct 31; 69(4):254-9. PubMed ID: 6219531
    [Abstract] [Full Text] [Related]

  • 10. [Clinical significance of antithrombin III with special reference to diabetic retinopathy (author's transl)].
    Matsuo T, Ohoki Y, Kondo S.
    Nihon Ronen Igakkai Zasshi; 1979 Nov 31; 16(6):551-5. PubMed ID: 119077
    [No Abstract] [Full Text] [Related]

  • 11. Hemostatic function tests associated with diabetic microangiopathy.
    Fuller JH.
    Horm Metab Res Suppl; 1981 Nov 31; 11():59-62. PubMed ID: 6947950
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The effect of recombinant human erythropoietin on hemostatic status in chronic uremic patients.
    Tsao CJ, Kao RH, Cheng TY, Huang CC, Chang SL, Lee FN.
    Int J Hematol; 1992 Apr 31; 55(2):197-203. PubMed ID: 1511168
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Effect of hemosorption on blood coagulation system factors in patients with severe suppurative infection].
    Shimkevich LL, Kostiuchenok BM, Rudneva VG, Chernov MI.
    Vestn Khir Im I I Grek; 1986 Apr 31; 136(4):111-4. PubMed ID: 3750633
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Hemostatic abnormalities of the patients with cancer. Clinical significance and fibrinolytic properties of the cancer tissues].
    Sato M.
    Nihon Geka Gakkai Zasshi; 1983 Jun 31; 84(6):471-87. PubMed ID: 6201715
    [Abstract] [Full Text] [Related]

  • 20. Increased hemostatic molecular markers in patients undergoing anticoagulant therapy.
    Wada H, Ikuma H, Mori Y, Shimura M, Hiyoyama K, Nakasaki T, Onoda K, Yamada N, Ohta T, Nishioka J, Sakuragawa N, Shiku H.
    Semin Thromb Hemost; 2000 Jun 31; 26(1):113-8. PubMed ID: 10805292
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.